A cardiologist's view of hormone replacement therapy and alternatives for cardioprotection.
Wenger
N K
NK
Department of Medicine, Division of Cardiology, Emory University School of Medicine, 69 Butler Street S.E., Atlanta, GA 30303, USA.
D001291:Attitude of Health Personnel; D002309:Cardiology; D003327:Coronary Disease / Q000453:epidemiology / Q000517:prevention & control*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects* / Q000379:methods / Q000592:standards*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008019:Life Style; D018579:Patient Selection; D011322:Primary Prevention / Q000379:methods*; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D013923:Thromboembolism / Q000139:chemically induced*; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D016387:Women's Health
D000960:Hypolipidemic Agents; D020845:Selective Estrogen Receptor Modulators